Regeneron Pharmaceuticals (REGN) Return on Capital Employed Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,780.00 |
| Dec 31, 2025 | -1,574.00 |
| Sep 30, 2025 | -1,328.00 |
| Jun 30, 2025 | -1,310.00 |
| Mar 31, 2025 | -713.00 |
| Dec 31, 2024 | -614.00 |
| Sep 30, 2024 | -710.00 |
| Jun 30, 2024 | -663.00 |
| Mar 31, 2024 | -992.00 |
| Dec 31, 2023 | -1,193.00 |
| Sep 30, 2023 | -1,110.00 |
| Jun 30, 2023 | -1,156.00 |
| Mar 31, 2023 | -1,172.00 |
| Dec 31, 2022 | -865.00 |
| Sep 30, 2022 | -61.00 |
| Jun 30, 2022 | 449.00 |
| Mar 31, 2022 | 1,621.00 |
| Dec 31, 2021 | 1,987.00 |
| Sep 30, 2021 | 1,775.00 |
| Jun 30, 2021 | 1,764.00 |
| Mar 31, 2021 | 117.00 |
| Dec 31, 2020 | -162.00 |
| Sep 30, 2020 | -690.00 |
| Jun 30, 2020 | -397.00 |
| Mar 31, 2020 | -884.00 |
| Dec 31, 2019 | -930.00 |
| Sep 30, 2019 | -610.00 |
| Jun 30, 2019 | -938.00 |
| Mar 31, 2019 | -521.00 |
| Dec 31, 2018 | -397.00 |
| Sep 30, 2018 | -468.00 |
| Jun 30, 2018 | -358.00 |
| Mar 31, 2018 | -131.00 |
| Dec 31, 2017 | 56.00 |
| Sep 30, 2017 | 667.00 |
| Jun 30, 2017 | 2,391.00 |
| Mar 31, 2017 | 3,559.00 |
| Dec 31, 2016 | 4,393.00 |
| Sep 30, 2016 | 4,144.00 |
| Jun 30, 2016 | 4,019.00 |
| Mar 31, 2016 | 3,813.00 |
| Dec 31, 2015 | 3,805.00 |
| Sep 30, 2015 | 4,772.00 |